Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
American Association of Clinical Endocrinology Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
McGill Janet B, Donihi Amy C, Akturk Halis K, Freeby Matthew, Gupta Abhinav, Horton William B, Jadoon M Nauman, Lathief Sanam, Miracle-Lopez Sigfrido, Tan Charity, Galindo Rodolfo J
Аннотация
OBJECTIVE: To provide evidence-informed guidance to assist with shared decision making in the use of advanced technology for the management of adults with diabetes mellitus.
METHODS: An international task force composed of AACE members with expertise in diabetology and endocrinology reviewed the recent evidence and developed updated guidance for advanced diabetes technology. Relevant studies were identified through a literature review process, and evidence was summarized with key practice points for use of technology in relevant populations. Consensus on the document was obtained through virtual meetings and communications with the task force.
RESULTS: The task force deliberated on areas where evidence supports the use of advanced diabetes technology in different populations of individuals with diabetes mellitus. Also discussed were best practices and implementation considerations for the successful adoption of diabetes technology by individuals with all types of diabetes and their health care professionals.
CONCLUSIONS: This consensus statement aims to provide updated information for health care professionals involved in care for adults with diabetes mellitus. It reviews current evidence that informs best practices in the use of continuous glucose monitoring devices, automated insulin-delivery systems, and other insulin delivery devices, in addition to emerging technologies such as continuous ketone monitoring.
METHODS: An international task force composed of AACE members with expertise in diabetology and endocrinology reviewed the recent evidence and developed updated guidance for advanced diabetes technology. Relevant studies were identified through a literature review process, and evidence was summarized with key practice points for use of technology in relevant populations. Consensus on the document was obtained through virtual meetings and communications with the task force.
RESULTS: The task force deliberated on areas where evidence supports the use of advanced diabetes technology in different populations of individuals with diabetes mellitus. Also discussed were best practices and implementation considerations for the successful adoption of diabetes technology by individuals with all types of diabetes and their health care professionals.
CONCLUSIONS: This consensus statement aims to provide updated information for health care professionals involved in care for adults with diabetes mellitus. It reviews current evidence that informs best practices in the use of continuous glucose monitoring devices, automated insulin-delivery systems, and other insulin delivery devices, in addition to emerging technologies such as continuous ketone monitoring.